You are here

Error message

The MailChimp PHP library is missing the required GuzzleHttp library. Please check the installation notes in README.txt.

Warning message

The subscription service is currently unavailable. Please try again later.


It is the aim of all developments within WP6 to provide new tools to facilitate Model-Based Drug Development (MBDD) in the pharmaceutical industry. Indeed, demands for MBDD go beyond the facilitation of interactions between existing software tools.

The demands include:

  • The building of mechanistic models that combine existing knowledge on the disease and the project level with new data from a recent experiment or study. New methodologies for parameter estimation in complex models will be developed.
  • The initial focus is on complex models for diabetes. Specific plans include: visual diagnostics for time-to-event models, guidance for model building with correlated covariates, and new types of normalised prediction distribution errors.
  • The simulation of future experiments or studies in order to support development decisions that lead to an optimal portfolio management. A second prototype of a Clinical Trial Simulator has been distributed for testing to interested EFPIA participants in the work package.
  • The optimal design of future experiments or studies. These are not just designs that increase the probability of success, but designs that deliver results within a reasonable timeframe and within a predefined budget.

Each of the four tasks within WP6 addresses one of these four demands. The specific challenges of WP6 are:

  • To develop new tools that will fit into a framework that itself is evolving during the lifespan of DDMoRe.
  • To develop new tools which meet the expectations of the customers, i.e. the EFPIA members in the consortium.
  • To develop new tools not from scratch but from existing tools which are already in use among the customers.
  • To find a balance between what is doable within the budget of DDMoRe and what is expected by the customer.



  • News posted on 8 years 3 months ago

    Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe’s European Federation of Pharmaceutical Industries and Associations Members. F Mentré, M... Read more

  • Project posted on 8 years 7 months ago

    Animation: Introduction to PK modelling generated for Education and Training DDMoRe Conception: Elena Carvajal & Marc Lavielle Execution: Elena Carvajal Scientific Coordinator: Marc Lavielle... Read more

  • Nov 09 to Nov 11, 2011
    United Kingdom
    Events posted on 9 years 9 months ago

    November 9 - 11, UK Presentation on first prototype Clinical Trial Simulator for DDMoRe by Marc Lavielle, INRIA